Excellence in early and late phase clinical trials across an expansive range of therapeutic areas.
MAC brings together a diverse set of capabilities and research experience for the benefit of pharma, biotech and CROs. Our ability to recruit participants and conduct clinical trials with expertise across an extensive range of medical conditions sets us apart from other research organisations.
Alzheimers DiseaseTimeline Recovery: MAC was approached 12 months into the trial and recruited a significant number of patients.
Atopic Dermatitis 1This study ran across 4 countries (UK, Germany, Belgium and Poland). MAC randomized 49% of the patients.
MCITimeline Recovery: The IMP was going out of date. MAC successfully delivered within timeframe (single site).
Peripheral Neuropathic PainThis complex in-patient clinical trial ran in 4 countries, but many sites did not recruit any patients.
MAC EnVision® patient engagement solutions provide access to an extensive range of therapeutic areas.